Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia ankara-HIV-1 vaccine candidate / J R CURRIER ; V NGAUY ; M S DE SOUZA ; et al. in PloS One, Vol. 5, n° 11 (novembre 2010)
[article]
[article]
|